Cesium carbonate → N,N-Dibutyl-4-chloro-1-(4-(1-(3,4-dichlorobenzyl)indolin-6-ylsulfonylcarbamoyl)-2-(1,2,3,4-tetrahydroisoquinoline-2-carbonyl)phenyl)-5-methyl-1H-pyrazole-3-carboxamide

HRID 528852

반응식

HRID 528852 반응식
Br[C:2]1[CH:3]=[C:4]2[C:8](=[CH:9][C:10]=1[S:11]([NH:14][C:15]([C:17]1[CH:22]=[CH:21][C:20]([N:23]3[C:27]([CH3:28])=[C:26]([Cl:29])[C:25]([C:30]([N:32]([CH2:37][CH2:38][CH2:39][CH3:40])[CH2:33][CH2:34][CH2:35][CH3:36])=[O:31])=[N:24]3)=[C:19]([C:41]([N:43]3[CH2:52][CH2:51][C:50]4[C:45](=[CH:46][CH:47]=[CH:48][CH:49]=4)[CH2:44]3)=[O:42])[CH:18]=1)=[O:16])(=[O:13])=[O:12])[N:7]([CH2:53][C:54]1[CH:59]=[CH:58][C:57]([Cl:60])=[C:56]([Cl:61])[CH:55]=1)[CH2:6][CH2:5]2.C(C1C=C(C(C)(C)C)C=CC=1OP(OC1C=CC(C(C)(C)C)=CC=1C(C)(C)C)OC1C=CC(C(C)(C)C)=CC=1C(C)(C)C)(C)(C)C.C([O-])([O-])=O.[Cs+].[Cs+]>CC(O)C.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd].[Pd]>[CH2:37]([N:32]([CH2:33][CH2:34][CH2:35][CH3:36])[C:30]([C:25]1[C:26]([Cl:29])=[C:27]([CH3:28])[N:23]([C:20]2[CH:21]=[CH:22][C:17]([C:15](=[O:16])[NH:14][S:11]([C:10]3[CH:9]=[C:8]4[C:4]([CH2:5][CH2:6][N:7]4[CH2:53][C:54]4[CH:59]=[CH:58][C:57]([Cl:60])=[C:56]([Cl:61])[CH:55]=4)=[CH:3][CH:2]=3)(=[O:12])=[O:13])=[CH:18][C:19]=2[C:41]([N:43]2[CH2:52][CH2:51][C:50]3[C:45](=[CH:46][CH:47]=[CH:48][CH:49]=3)[CH2:44]2)=[O:42])[N:24]=1)=[O:31])[CH2:38][CH2:39][CH3:40]

참가 물질

6

반응물 3

HCID 10796Cesium carbonateHCID 91601Tris(2,4-di-tert-butylphenyl) phosphiteHCID 867188911-(4-(5-bromo-1-(3,4-dichlorobenzyl)indolin-6-ylsulfonylcarbamoyl)-2-(1,2,3,4-tetrahydroisoquinoline-2-carbonyl)phenyl)-N,N-dibutyl-4-chloro-5-methyl-1H-pyrazole-3-carboxamide

생성물 1

HCID 71062147N,N-Dibutyl-4-chloro-1-(4-(1-(3,4-dichlorobenzyl)indolin-6-ylsulfonylcarbamoyl)-2-(1,2,3,4-tetrahydroisoquinoline-2-carbonyl)phenyl)-5-methyl-1H-pyrazole-3-carboxamide수율 54.3%

시약·촉매·용매 2

HCID 9811564Bis(dibenzylideneacetone)palladium촉매HCID 3776Isopropanol용매

반응 조건

온도
80 °C

실험 절차

To a solution of 1-(4-(5-bromo-1-(3,4-dichlorobenzyl)indolin-6-ylsulfonylcarbamoyl)-2-(1,2,3,4-tetrahydroisoquinoline-2-carbonyl)phenyl)-N,N-dibutyl-4-chloro-5-methyl-1H-pyrazole-3-carboxamide (Example 72, 30 mg, 0.031 mmol) in i-PrOH (4.0 mL) were added Pd2(dba)3 (23 mg, 0.025 mmol), tris(2,4-di-tert-butylphenyl)phosphite (10 mg, 0.015 mmol) and Cs2CO3 (13 mg, 0.040 mmol). The resulting reaction mixture was heated at 80° C. for 20 h, then cooled to room temperature and filtered. The filtrate was concentrated in vacuo, and the residue was purified by preparative HPLC to give the title compound (15 mg, 52%) as a pale yellow solid after lyophilization. 1H NMR (CD3OD, 2:1 mixture of amide rotamers) δ 8.05 (dd, J=8.4, 2.2 Hz, 1H), 7.97-7.96 (m, 1H), 7.71-7.67 (m, 1H), 7.52 (d, J=2.0 Hz, 1H), 7.46 (d, J=8.1 Hz, 1H), 7.38 (dd, J=7.7, 1.5 Hz, 1H), 7.31 (dd, J=8.4, 2.0 Hz, 1H), 7.25-7.10 (m, 5.5H), 6.93 (d, J=7.5 Hz, 0.5H), 4.88-4.60 (m, 2H), 4.36 (s, 2H), 4.10-3.50 (m, 2H), 3.48 (t, J=8.5 Hz, 2H), 3.15-3.05 (m, 2H), 3.08 (t, J=8.5 Hz, 2H), 2.90-2.70 (m, 2H), 2.35 (s, 2H), 2.30 (s, 1H), 1.53-0.98 (m, 10H), 0.95-0.88 (m, 3H), 0.79-0.75 (m, 2H), 0.70 (t, J=7.3 Hz, 1H); MS(ESI+) m/z 891.4 (M+H)+.

후처리

  1. customThe resulting reaction mixture
  2. temperaturecooled to room temperature
  3. filtrationfiltered
  4. concentrationThe filtrate was concentrated in vacuo
  5. customthe residue was purified by preparative HPLC

출처 및 근거

ORD 기록
ord-f8c1bf2d818649eca1fc72c8d35d0b11
출처 데이터셋
uspto-grants-2016_05
특허 번호
US09346795B2

연결된 노트

불러오는 중…